𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epipodophyllotoxin (VP16-213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapy

✍ Scribed by P. G. Harper; M. B. Dally; D. M. Geddes; S. G. Spiro; J. F. Smyth; R. L. Souhami

Publisher
Springer
Year
1982
Tongue
English
Weight
168 KB
Volume
7
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

✦ Synopsis

Thirty-eight patients with small cell carcinoma of the bronchus resistant to initial chemotherapy with cyclophosphamide methotrexate and CCNU, were treated with VP16-213 alone in a dose of 120 mg/m2 i.v. on days 1, 3, and 5 every 3 weeks. Twelve patients died before three courses of treatment. In 26 patients who received three or more courses only one, transient partial response occurred. One or more components of the initial chemotherapy seems to confer resistance to the action of VP16-213 in this disease.

πŸ“œ SIMILAR VOLUMES

Chemotherapy combination with cyclophosp
Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL)
✍ J. M. Gracia; A. Jimenez πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 178 KB

Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2

Vincristine, adriamycin, cyclophosphamid
Vincristine, adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung
✍ F. E. Eyben; Γ…. Arwidi; C. Hellekant; K. Jonsson; S. Γ…. Lindahl; W. Mattsson; L. πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 299 KB

Twelve patients with small-cell anaplastic carcinoma of the lung were treated with vincristine 1 mg/m2 i.v. day 1, adriamycin 50 mg/M2 i.v. day 1, cyclophosphamide 1,000 mg/m2 i.v. day 1, and etoposide 80 mg/m2 i.v. day 2, 4, 6 given on an outpatient basis and repeated at 3-week intervals. As consol

The addition of cisplatin to cyclophosph
The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients
✍ Thierry Urban; Claude Chastang; FranΓ§ois-Xavier Lebas; Jean-Paul Duhamel; Guy Ad πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel